新疆边境跨界动物疫病传入风险因素调查

新疆地域辽阔,周边国家动物疫情形势复杂,随时有传入外来动物疫病的危险。调查结果表明新疆接壤国家多且边境线长,地理环境复杂,动物及动物产品贸易频繁,野生动物种类繁多,虽然边界线隔离设施较好,但仍然存在跨界动物疫病传入的风险因素,需要有针对性地强化边境防控措施。     

枯草芽孢杆菌制剂对蛋鸡生产性能、蛋品质和养分消化率的影响

选择健康、产蛋均匀的45周龄尼克珊瑚粉蛋鸡540只,随机分为3组,每组6个重复,每个重复30只鸡,其中两个组为试验组,另一组为对照组.采用单因子试验设计,试验组分别在基础日粮中添加250、500mg/kg的枯草芽孢杆菌制剂,对照组饲喂基础日粮,进行为期4周的试验,研究日粮中添加枯草芽孢杆菌制剂对产蛋鸡生产性能、蛋品质及营养物质消化率的影响.结果表明:①在蛋鸡日粮中添加枯草芽孢杆菌制剂具有改善料蛋比、降低死淘率、显著降低鸡蛋破损率(P<0.05)、提高个蛋重和蛋壳厚度的趋势.②蛋鸡日粮中添加枯草芽孢杆菌制剂显著提高了日粮粗蛋白和有机物消化率(P<0.05).     

大针茅根系构型对草地退化的响应

本研究对锡林郭勒典型草原区轻度、中度、重度和极度4个退化梯度草地中大针茅(Stipa grandis)根系构型进行研究。结果表明,1）根分叉数、根表面积和总根长3个参数是分析大针茅根系构型在不同退化程度草地中变化的主要指标,其中根分叉数对该变化的解释力最强,3个参数的累积贡献率为90.7%;2）从轻度、重度到极度退化程度的草地系列中,大针茅的根系构型小型化趋势明显;3）中度退化程度的草地中大针茅根系构型小型化特别明显;4）根系构型小型化最终导致整个植物体小型化,因此在群落退化演替进程中大针茅的建群种作用逐渐减弱并最终为其他优势种取代。     

家蚕有滞育多化性品种滞育卵复式冷藏继代法的研究

利用上年中秋制种的滞育卵经复式冷藏处理,到当年夏蚕期饲养,夏制种再经中秋蚕期饲养,进行了有滞育多化性品种的省力保种试验.夏蚕期其生命力较对照组低1.2%~1.9%,生种率上升16.0%,差异达显著程度.中秋蚕期生命力高1.0%,生种率低0.9%,完全恢复正常.重复试验,结果一致.有滞育多化性品种用滞育卵复式冷藏处理一年二次省力保种是可行的.     

饲养方式对蛋鸡产蛋前期生产性能的影响

试验通过对比舍外散放蛋鸡与舍内笼养蛋鸡在体重、胫长和胫围等方面的差异来研究饲养方式对鸡产蛋前期生产性能的影响.结果表明:散放鸡体重在8、10、12周龄显著低于同周龄笼养鸡;散放鸡胫长在10、12周龄显著低于同周龄笼养鸡;散放鸡胫围在10周龄显著低于同周龄笼养鸡.笼养鸡和散放鸡各周龄的胫长和胫围变异系数均小于10%,均匀...     

硫酸新霉素可溶性粉在靶动物猪的安全性研究

为了客观评价硫酸新霉素可溶性粉对靶动物猪临床应用的安全性,将32头仔猪随机分为4组,每组8头,分别设1倍、3倍、5倍临床推荐剂量组和空白对照组,连续混饮硫酸新霉素可溶性粉15 d,通过检测各组受试猪的临床表现、血液常规指标、血清生化指标、尿液常规指标及病理学变化等评价其临床用药的安全性。结果:硫酸新霉素可溶性粉以5倍临床推荐剂量内应用于靶动物猪后,对其临床症状、体重、血常规、血生化及尿常规等指标没有显著影响,解剖学及病理组织学检查也未见任何病理变化,说明硫酸新霉素可溶性粉以1倍、3倍、5倍临床推荐剂量应用于靶动物猪是安全的。     

Cardiomyopathy in Dystrophin-Deficient Hypertrophic Feline Muscular Dystrophy

A colony of cats affected with hypertrophic feline muscular dystrophy was used to study the occurrence of cardiomyopathy associated with dystrophin deficiency. Affected male and female cats, obligate carrier females, and unaffected healthy littermates were followed from 12 weeks of age into adulthood. Thoracic radiography, 2-D echocardiography, and 2-D-derived M-mode echocardiography were performed at 3-month intervals until 12 months of age and regularly thereafter. From 9 months of age, all affected cats had larger hearts than normal and carrier animals. Left ventricular wall thickness in systole and in diastole and interventricular septal thickness in systole were greater in affected cats 12 months and older when compared with normal or heterozygous animals (P < .05). The myocardium of affected cats was diffusely hypoechoic and thickened. Multiple hyperechoic foci were in the myocardium and papillary musculature. Shortening fraction was normal in all cats. Changes seen in carrier females included enlargement and hyperechogenicity of the papillary musculature after the age of 2 years. Gross and light microscopic examination revealed left ventricular wall thickening with multiple foci of mineralization in 2 of 5 hearts from dystrophin-deficient cats. Although approximately 10% of the normal dystrophin amount was present in the skeletal muscle, dystrophin could not be detected in the myocardium. Early onset concentric myocardial hypertrophy was present in all adult cats. Lesions were mainly localized in the myocardium of the left ventricular free wall and interventricular septum, papillary musculature, and the endocardium. Clinical signs of heart failure developed only infrequently in cats with hypertrophic feline muscular dystrophy.     

Regulation of fibroblast growth factor 9 on the differentiation of goat intramuscular adipocytes

It has been found that fibroblast growth factor receptor (FGF-FGFR) signaling can regulate the expression of adipocyte differentiation genes. FGF9 is one of the members of FGFs that mainly binds receptors FGFR2 and FGFR3. FGF9 is highly expressed in the adipose tissue of humans and mice, but there are few reports on the role of FGF9 in goat intramuscular adipocyte differentiation. Therefore, this study explored the effect of FGF9 on adipocyte differentiation through cell culture, interference, and overexpression. The expression of receptors FGFR1–FGFR4 in adipocyte differentiation and their effects on differentiation were detected to screen receptor gene of FGF9. Finally, the interaction between FGF9 and the receptor was tested by cotransfection. Our results showed that FGF9 interacts with FGFR2 to inhibit goat intramuscular adipocyte differentiation by regulating peroxisome proliferator-activated receptor gamma (PPARγ) and preadipocyte factor 1 (Pref1), which is a data support for subsequent pathway research.